— Company named “Best Financially Managed Semiconductor Company (Achieving Greater than $1 Billion in Annual Sales)” and “Outstanding Asia-Pacific Semiconductor Company” simultaneously — Accelerates recovery from market downturn leveraging world-class HBM leadership; Global management performance recognized — Reflects company's technology leadership and customer-centric execution — SK Chairman Chey Tae-won emphasizes: “Technological competitiveness must remain unwavering […]

Washington, DC, Dec. 06, 2025 (GLOBE NEWSWIRE) — ThinkCareBelieve's Week 46 Article: https://thinkcarebelieve.blog/2025/12/06/week-46-america-shining-brightly/ The 2025 National Security Strategy Article: https://thinkcarebelieve.blog/2025/12/06/the-2025-national-security-strategy-2/ America's Weekly Golden Chronicle: https://thinkcarebelieve.blog/2025/12/01/americas-weekly-golden-chronicle-list/ Washington, D.C. – ThinkCareBelieve today released a comprehensive review of Week 46 of the second Trump Administration, describing it as a period of remarkable intensity paired with calm resolve, marked

ThinkCareBelieve: Week 46 America Shining Brightly Week 46 of the Trump 2.0 Administration GlobeNewswire December 06, 2025 Washington, DC, Dec. 06, 2025 (GLOBE NEWSWIRE) — ThinkCareBelieve's Week 46 Article: https://thinkcarebelieve.blog/2025/12/06/week-46-america-shining-brightly/ The 2025 National Security Strategy Article: https://thinkcarebelieve.blog/2025/12/06/the-2025-national-security-strategy-2/ America's Weekly Golden Chronicle: https://thinkcarebelieve.blog/2025/12/01/americas-weekly-golden-chronicle-list/ Washington, D.C. – ThinkCareBelieve today released a comprehensive review of Week 46 of

NEW YORK CITY, NY / ACCESS Newswire / December 6, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against DexCom, Inc. ("DexCom" or the "Company") (NASDAQ:DXCM) and certain officers.�� The class action, filed in the United States District Court for the Southern District of New York, and docketed under 25-cv-08912,

NEW YORK CITY, NY / ACCESS Newswire / December 6, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against MoonLake Immunotherapeutics ("Moonlake" or the "Company") (NASDAQ:MLTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

NEW YORK CITY, NY / ACCESS Newswire / December 6, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Telix Pharmaceuticals Limited ("Telix" or the "Company") (NASDAQ:TLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

NEW YORK CITY, NY / ACCESS Newswire / December 6, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against WPP Plc ("WPP" or the "Company") (NYSE:WPP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

NEW YORK CITY, NY / ACCESS Newswire / December 6, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Marex Group Plc ("Marex" or the "Company") (NASDAQ:MRX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

NEW YORK CITY, NY / ACCESS Newswire / December 6, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Cepton, Inc. ("Cepton" or the "Company") (NASDAQ:CPTN) and certain officers.�� The class action, filed in the United States District Court for the Northern District of California, and docketed under 25-cv-08571, is

NEW YORK CITY, NY / ACCESS Newswire / December 6, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against James Hardie Industries plc ("James Hardie" or the "Company") (NYSE:JHX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by